How should you know the usage and dosage of Capisete Tablets/Caposetinib?

Capivasertib tablets/Capivasertib (Capivasertib) is an oralAKT kinase inhibitor, mainly used to treat hormone receptors (H R)-positive and human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer patients who are also accompanied by PIK3CA, AKT1 or PTEN gene alterations and have had disease progression during endocrine therapy or relapse within 12 months after adjuvant therapy. The combination of carpisetin and fulvestrant can target and inhibit tumor cell signaling pathways, thereby delaying disease progression.

In terms of medication regimen, the recommended dose of capizetin is 400 mg per time taken orally twice a day. Patients can choose to take it with food or alone on an empty stomach. The flexible medication method improves patients' medication compliance. The drug adopts a cyclic administration mode. After taking it for 4 days, it will be stopped for 3 days, forming a 7-day cycle. This design takes into account the efficacy and safety of the drug, can reduce adverse reactions caused by continuous use, and help patients gain better treatment tolerance.

The strategy of periodic drug withdrawal is to give the body a chance to recover and reduce the risk of toxic side effects. Patients need to pay close attention to their own reactions while taking the medication, and regularly undergo hematology and liver and kidney function tests arranged by their doctors to detect abnormalities in a timely manner to ensure medication safety. For patients who experience serious side effects, doctors may adjust the dose or extend the withdrawal time based on the specific situation.

In addition, strict compliance with medical instructions is key to ensuring the success of carpizetine treatment. Patients are not allowed to adjust the dosage or stop medication without authorization. Any medication changes should be made under the guidance of a professional doctor to avoid affecting the efficacy or even worsening the condition. Regular follow-up and imaging evaluation are also important parts of treatment monitoring, helping doctors adjust treatment plans in a timely manner.

Reference materials:https://www.drugs.com/mtm/capivasertib.html